Quantcast

Latest DURECT Corporation Stories

2010-07-29 15:15:00

CUPERTINO, Calif., July 29 /PRNewswire-FirstCall/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) second quarter 2010 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Wednesday, August 4, 2010 at 4:30 pm Eastern Time (1:30 pm Pacific Time). (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO) A live audio webcast of the...

2010-07-28 15:15:00

CUPERTINO, Calif., July 28 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Matthew J. Hogan, Chief Financial Officer, will be presenting at the BMO Capital Markets 10th Annual Focus on Healthcare Conference on Thursday, August 5 at 1:45 p.m. Eastern Time. The conference is being held at the Sheraton New York Hotel. (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO) A live audio...

2010-07-01 15:30:00

CUPERTINO, Calif., July 1 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it has secured a committed equity financing facility under which it may sell up to $50 million of its registered common stock to Azimuth Opportunity Ltd. for a term of 24 months. DURECT is not obligated to utilize any of the $50 million facility. DURECT did not pay a commitment fee or issue any warrants to secure this facility. (Logo:...

2010-06-16 15:30:00

CUPERTINO, Calif., June 16 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today results from a European Phase IIb hysterectomy clinical trial conducted by Nycomed of POSIDUR(TM) (also known as SABER(TM)-bupivacaine or Optesia(TM) in the E.U.), a proprietary product under development for the treatment of post-surgical pain. (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO) This hysterectomy...

2010-06-07 15:10:00

CUPERTINO, Calif., June 7 /PRNewswire-FirstCall/ -- In conjunction with the announcement of a POSIDUR(TM) (SABER(TM)-Bupivacaine) collaboration between DURECT Corporation (Nasdaq: DRRX) and Hospira, Inc. (NYSE: HSP), you are invited to listen to a conference call that will be broadcast live over the internet on Monday, June 7, 2010 at 5:00 pm Eastern Time (2:00 pm Pacific Time). (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be...

2010-06-07 15:05:00

LAKE FOREST, Ill. , and CUPERTINO, Calif., June 7 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, and DURECT Corporation, a specialty pharmaceutical company (Nasdaq: DRRX), today announced that the companies have entered into a licensing agreement to develop and market DURECT's POSIDUR(TM) (SABER(TM)-bupivacaine) a long-acting version of the anesthetic bupivacaine currently in Phase III clinical trials. Hospira will...

2010-06-01 16:00:00

CUPERTINO, Calif., June 1 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that James E. Brown, President and Chief Executive Officer, will be presenting at the Jefferies Global Life Sciences Conference on Thursday, June 10 at 10:30 a.m. Eastern Time. The conference is being held at the Grand Hyatt Hotel in New York. (Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing...

2010-05-13 15:15:00

CUPERTINO, Calif., May 13 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Matt Hogan, Chief Financial Officer, will be presenting at the Rodman & Renshaw Global Healthcare Conference on Monday, May 17 at 4:30 p.m. London time (11:30 am Eastern Time). The conference is being held at the Grosvenor House Hotel in London. (Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by...

2010-05-10 15:05:00

CUPERTINO, Calif., May 10 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the three months ended March 31, 2010. Total revenues were $7.7 million for the three months ended March 31, 2010 and $6.2 million for the three months ended March 31, 2009. Net loss for the three months ended March 31, 2010 was $6.6 million, compared to a net loss of $8.7 million for the same period in 2009. (Logo:...

2010-05-04 06:00:00

CUPERTINO, Calif., May 4 /PRNewswire-FirstCall/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) first quarter 2010 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Monday, May 10, 2010 at 4:30 pm Eastern Time (1:30 pm Pacific Time). (Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing DURECT's homepage at...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related